サマリー

自己免疫性溶血性貧血治療薬の世界市場 2022-2026 年
Technavioは自己免疫性溶血性貧血治療薬市場を監視しており、2022-2026年の間に2億6822万ドル、予測期間中にCAGR9.1％で加速して成長すると予測しています。当レポートでは、自己免疫性溶血性貧血治療薬市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、規制による優遇措置、患者支援プログラム、輸血や脾臓摘出術に伴う副作用や合併症によって牽引されています。
自己免疫性溶血性貧血治療薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioの自己免疫性溶血性貧血治療薬市場は、以下のようにセグメント化されています。
製品別
- 副腎皮質ホルモン
- モノクローナル抗体
- その他
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、新規治療薬の研究開発が、今後数年間の自己免疫性溶血性貧血治療薬市場の成長を牽引する主要な理由の一つであると位置付けています。また、マウスモデルの進歩や併用療法の開発は、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。自己免疫性溶血性貧血治療薬市場に関する当レポートは、以下の分野を対象としています。
- 自己免疫性溶血性貧血治療薬の市場サイジング
- 自己免疫性溶血性貧血治療薬の市場予測
- 自己免疫性溶血性貧血治療薬市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AstraZeneca Plc、Amneal Pharmaceuticals Inc.を含む複数の自己免疫性溶血性貧血治療薬市場の主要ベンダーについて詳細に分析しています。ANI Pharmaceuticals Inc.、Apellis Pharmaceuticals Inc.、argenx SE、Baxter International Inc.、Cipla Ltd.、Concord Biotech Ltd.、F. Hoffmann La Roche Ltd., Hikma Pharmaceuticals Plc、Incyte Corp.、Kezar Life Sciences Inc.、Nichi-Iko Pharmaceutical Co.Ltd.、Rigel Pharmaceuticals Inc.、Sanofi SA、Teva Pharmaceutical Industries Ltd.、Viatris Inc.などです。また、自己免疫性溶血性貧血治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/autoimmune-hemolytic-anemia-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Corticosteroids - Market size and forecast 2021-2026
o Exhibit 28: Chart on Corticosteroids - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Corticosteroids - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Corticosteroids - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Corticosteroids - Year-over-year growth 2021-2026 (%)
o 5.4 Monoclonal antibodies - Market size and forecast 2021-2026
o Exhibit 32: Chart on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
o 5.5 Others - Market size and forecast 2021-2026
o Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product
o Exhibit 40: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share by geography 2021-2026 (%)
o Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 82: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AstraZeneca Plc
o Exhibit 89: AstraZeneca Plc - Overview
o Exhibit 90: AstraZeneca Plc - Product / Service
o Exhibit 91: AstraZeneca Plc - Key news
o Exhibit 92: AstraZeneca Plc - Key offerings
o 10.4 Amneal Pharmaceuticals Inc.
o Exhibit 93: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 94: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 95: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 96: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 97: Amneal Pharmaceuticals Inc. - Segment focus
o 10.5 Baxter International Inc.
o Exhibit 98: Baxter International Inc. - Overview
o Exhibit 99: Baxter International Inc. - Business segments
o Exhibit 100: Baxter International Inc. - Key news
o Exhibit 101: Baxter International Inc. - Key offerings
o Exhibit 102: Baxter International Inc. - Segment focus
o 10.6 Concord Biotech Ltd.
o Exhibit 103: Concord Biotech Ltd. - Overview
o Exhibit 104: Concord Biotech Ltd. - Product / Service
o Exhibit 105: Concord Biotech Ltd. - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 106: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 107: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 108: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 109: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 110: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 Incyte Corp.
o Exhibit 111: Incyte Corp. - Overview
o Exhibit 112: Incyte Corp. - Business segments
o Exhibit 113: Incyte Corp. - Key offerings
o Exhibit 114: Incyte Corp. - Segment focus
o 10.9 Kezar Life Sciences Inc.
o Exhibit 115: Kezar Life Sciences Inc. - Overview
o Exhibit 116: Kezar Life Sciences Inc. - Product / Service
o Exhibit 117: Kezar Life Sciences Inc. - Key news
o Exhibit 118: Kezar Life Sciences Inc. - Key offerings
o 10.10 Rigel Pharmaceuticals Inc.
o Exhibit 119: Rigel Pharmaceuticals Inc. - Overview
o Exhibit 120: Rigel Pharmaceuticals Inc. - Product / Service
o Exhibit 121: Rigel Pharmaceuticals Inc. - Key offerings
o 10.11 Sanofi SA
o Exhibit 122: Sanofi SA - Overview
o Exhibit 123: Sanofi SA - Business segments
o Exhibit 124: Sanofi SA - Key news
o Exhibit 125: Sanofi SA - Key offerings
o Exhibit 126: Sanofi SA - Segment focus
o 10.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 127: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 128: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 129: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 130: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 131: Teva Pharmaceutical Industries Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 132: Inclusions checklist
o Exhibit 133: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 134: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 135: Research methodology
o Exhibit 136: Validation techniques employed for market sizing
o Exhibit 137: Information sources
o 11.5 List of abbreviations
o Exhibit 138: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Corticosteroids - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Corticosteroids - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Corticosteroids - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Corticosteroids - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share by geography 2021-2026 (%)
Exhibits43: Data Table on Market share by geography 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity by geography ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AstraZeneca Plc - Overview
Exhibits90: AstraZeneca Plc - Product / Service
Exhibits91: AstraZeneca Plc - Key news
Exhibits92: AstraZeneca Plc - Key offerings
Exhibits93: Amneal Pharmaceuticals Inc. - Overview
Exhibits94: Amneal Pharmaceuticals Inc. - Business segments
Exhibits95: Amneal Pharmaceuticals Inc. - Key news
Exhibits96: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits97: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits98: Baxter International Inc. - Overview
Exhibits99: Baxter International Inc. - Business segments
Exhibits100: Baxter International Inc. - Key news
Exhibits101: Baxter International Inc. - Key offerings
Exhibits102: Baxter International Inc. - Segment focus
Exhibits103: Concord Biotech Ltd. - Overview
Exhibits104: Concord Biotech Ltd. - Product / Service
Exhibits105: Concord Biotech Ltd. - Key offerings
Exhibits106: F. Hoffmann La Roche Ltd. - Overview
Exhibits107: F. Hoffmann La Roche Ltd. - Business segments
Exhibits108: F. Hoffmann La Roche Ltd. - Key news
Exhibits109: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits110: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits111: Incyte Corp. - Overview
Exhibits112: Incyte Corp. - Business segments
Exhibits113: Incyte Corp. - Key offerings
Exhibits114: Incyte Corp. - Segment focus
Exhibits115: Kezar Life Sciences Inc. - Overview
Exhibits116: Kezar Life Sciences Inc. - Product / Service
Exhibits117: Kezar Life Sciences Inc. - Key news
Exhibits118: Kezar Life Sciences Inc. - Key offerings
Exhibits119: Rigel Pharmaceuticals Inc. - Overview
Exhibits120: Rigel Pharmaceuticals Inc. - Product / Service
Exhibits121: Rigel Pharmaceuticals Inc. - Key offerings
Exhibits122: Sanofi SA - Overview
Exhibits123: Sanofi SA - Business segments
Exhibits124: Sanofi SA - Key news
Exhibits125: Sanofi SA - Key offerings
Exhibits126: Sanofi SA - Segment focus
Exhibits127: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits128: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits129: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits130: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits131: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits132: Inclusions checklist
Exhibits133: Exclusions checklist
Exhibits134: Currency conversion rates for US$
Exhibits135: Research methodology
Exhibits136: Validation techniques employed for market sizing
Exhibits137: Information sources
Exhibits138: List of abbreviations